跳至主要内容
临床试验/NCT02956213
NCT02956213已完成不适用

Assessing the Effect of Different Efficiency Indoor Air Filters on Respiratory Symptoms in Former Smokers

Intermountain Health Care, Inc.2 个研究点 分布在 1 个国家目标入组 52 人开始时间: 2016年11月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
52
试验地点
2
主要终点
Change in SGRQ-C score

研究概览

简要总结

The investigators will conduct a randomized, controlled, double-blind, crossover trial to determine whether the presence of a portable high-efficiency indoor air filter in the bedroom reduces respiratory symptoms in former smokers compared with placebo. The primary outcomes will be change in St. George's Respiratory Questionnaire - COPD (SGRQ-C) score associated with using a portable high-efficiency indoor air filter during the study period. Secondary outcomes of COPD exacerbations and hospitalizations, daily step counts, medication changes, spirometry, and cardiovascular outcomes will also be assessed.

详细描述

Hypothesis/Research Questions:

This study will determine whether the presence of a portable high-efficiency indoor air filter in the bedroom improves respiratory symptoms (based on St. George's Respiratory Questionnaire - COPD - SGRQ-C score) during a period of high air pollution compared with placebo in former smokers with respiratory symptoms.

The primary outcome will be the change in SGRQ-C score associated with using a portable high-efficiency indoor air filter during the study period.

Secondary outcomes will assess the effect of using a portable high-efficiency indoor air filter on healthcare utilization, other symptom scores, COPD exacerbation frequency, medication use, median daily step counts, inflammatory markers, oxygenation, indoor particulate counts and indoor-outdoor particulate count difference, and pulmonary function tests.

Baseline descriptive statistics will report baseline air filter type, duration of use, and particulate weight prior to study enrollment.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Prevention
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
40 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • history of smoking
  • Do not currently smoke and no one currently smokes inside the home
  • history of exacerbation or development of respiratory symptoms (e.g.cough, sputum production, chest tightness, exertional dyspnea, etc.) with periods of high outdoor air pollution ("inversions")
  • Age 40 or older
  • Access to Wi-Fi
  • Access to a cell phone, tablet or personal computer

排除标准

  • active tobacco use of subject
  • active tobacco use in the home
  • pre-existing use of a HEPA filter in the subject's bedroom

研究组 & 干预措施

ARM 1 MERV17 first

Experimental

This group will receive a portable HEPA air filtering device with MERV17 air filter for the first part of the study. At cross over, this group will receive the "placebo" or no high-efficiency filter.

干预措施: HEPA portable air filter (Other)

ARM 2 MERV17 second

Active Comparator

This group will receive a HEPA portable air filter with no high efficiency air filter for the first part of the study. At cross over, this group will receive the high-efficiency MERV17 air filter.

干预措施: Sham Control/Active Comparator (Other)

结局指标

主要结局

Change in SGRQ-C score

时间窗: 12 weeks

based on St. George's Respiratory Questionnaire - COPD - SGRQ-C score

次要结局

  • Effect of air filtration on healthcare utilization(6 months)
  • Aggregated assessment of the effect of air filtration on COPD exacerbation frequency(6 months)
  • Change in 6 minute walk test(3 months)
  • Number of cardiovascular events(6 months)
  • Change in median daily step counts(6 months)
  • Change in inflammatory markers(6 months)
  • Change in spirometry(3 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验